In particular, long-term exposure to cisplatin, which has been reported to induce NF-κB and TNF expression in various types of cancer cells, induces ITF2 deletion in non-small cell lung cancer (NSCLC), implying an association between ITF2 and inflammation25. Here, TCF4 is linked to non-small cell lung carcinoma.